EVALUATION OF PARAOXONASE, ARYLESTERASE, AND HOMOCYSTEINE THIOLACTONASE ACTIVITIES IN PATIENTS WITH DIABETES AND INCIPIENT DIABETES NEPHROPATHY

被引:12
作者
Ayan, Durmus [1 ]
Senes, Mehmet [2 ]
Cayci, Ayse Banu [1 ]
Soylemez, Sibel [1 ]
Eren, Nezaket [3 ]
Altuntas, Yuksel [4 ]
Ozturk, Feyza Yener [4 ]
机构
[1] Gazi Univ, Med Biochem, Fac Med, Ankara, Turkey
[2] Hlth Sci Univ, Ankara Educ & Res Hosp, Med Biochem, Ankara, Turkey
[3] Yeni Yuzyil Univ, Fac Med, Med Biochem, Istanbul, Turkey
[4] Hlth Sci Univ, Endocrinol, Sisli Hamidiye Etfal Educ & Res Hosp, Istanbul, Turkey
关键词
paraoxonase; arylesterase; homocysteine thiolactonase; HIGH-DENSITY-LIPOPROTEIN; SERUM PARAOXONASE; CARDIOVASCULAR-DISEASE; ANTIOXIDANT CAPACITY; OXIDATIVE STRESS; DETERMINANTS; CHILDREN; PROTEIN;
D O I
10.2478/jomb-2019-0014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: The aim of this study is to examine the relationship among the changes in activities of paraoxonase (PON), arylesterase (ARE) and homocysteine thiolactonase (HTLase) enzyme having antioxidant properties and the development of diabetic nephropathy (DN), one of the most common complications of diabetes. Methods: Normoalbuminuric type-2 diabetic patients (Group II, n=100), microalbuminuric type 2 diabetic patients (Group III, n=100) and the control group (Group I, n=100) were included in the study. The age and gender of the patient groups matched with the age and gender of the control group. HTLase, PON and ARE enzyme activities were measured by the spectrophotometric method using a y-thiobutyrinolactone, paraoxon, and phenylacetate substrates respectively. In this study, an autoanalyzer application was developed in order to measure HTLase enzyme activity for the first time. Results: Serum HTLase, ARE and PON activities of Group Ill and Group II were significantly low compared to HTLase, ARE and PON results of Group I (p<0.05). Conclusions: Based on our results, PON, ARE and HTLase enzyme activities were found to be decreased due to the increase in the degree of DN.
引用
收藏
页码:481 / 488
页数:8
相关论文
共 33 条
[21]  
Pasupulati Anil Kumar, 2016, BioMolecular Concepts, V7, P293, DOI 10.1515/bmc-2016-0021
[22]   Paraoxonase 1 protects against protein N-homocysteinylation in humans [J].
Perla-Kajan, Joanna ;
Jakubowski, Hieronim .
FASEB JOURNAL, 2010, 24 (03) :931-936
[23]  
Sabah A. M., 2015, CLIN MED DIAGNOSTICS, V5, P26
[24]   Paraoxonase (PON)-1: a brief overview on genetics, structure, polymorphisms and clinical relevance [J].
Shunmoogam, Nelusha ;
Naidoo, Poobalan ;
Chilton, Robert .
VASCULAR HEALTH AND RISK MANAGEMENT, 2018, 14 :137-143
[25]   THE MONITORING OF PROTEIN MARKERS OF INFLAMMATION AND SERUM LIPID CONCENTRATION IN OBESE SUBJECTS WITH METABOLIC SYNDROME [J].
Sladoje, Dragana Puhalo ;
Kisic, Bojana ;
Miric, Dijana .
JOURNAL OF MEDICAL BIOCHEMISTRY, 2017, 36 (04) :366-374
[26]  
Suvarna R, 2011, J CLIN DIAGN RES, V5, P63
[27]   Urotensin-II level and its association with oxidative stress in early diabetic nephropathy [J].
Tabur, Suzan ;
Korkmaz, Hakan ;
Eren, Mehmet Ali ;
Oguz, Elif ;
Sabuncu, Tevfik ;
Aksoy, Nurten .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (01) :115-119
[28]  
Turkoglu S., 2008, Firat Tip Dergisi, V13, P110
[29]   POTENTIAL PROGNOSTIC ROLE OF IMMUNE SYSTEM ACTIVATION MARKER NEOPTERIN IN PATIENTS WITH TYPE 2 DIABETES [J].
Unuvar, Songul ;
Tanriverdi, Zubeyde ;
Aslanhan, Hamza .
JOURNAL OF MEDICAL BIOCHEMISTRY, 2018, 37 (04) :465-469
[30]   Low High-Density Lipoprotein Cholesterol Is Not Responsible for Decreased Paraoxonase Activity in Chronic Renal Failure [J].
Varga, Eva ;
Seres, Ildiko ;
Harangi, Mariann ;
Karpati, Istvan ;
Koncsos, Peter ;
Sztanek, Ferenc ;
Paragh, Gyorgy .
KIDNEY & BLOOD PRESSURE RESEARCH, 2012, 35 (04) :265-272